Blood pressure drug recalled for possible cross-contamination

https://www.msn.com/en-us/health/other/blood-pressure-drug-recalled-for-possible-cross-contamination/ar-AA1RQr2x

Thousands of bottles of a commonly used prescription drug to treat hypertension has been recalled for possible contamination with another drug.

Glenmark Pharmaceuticals Inc., which has U.S. headquarters in Elmwood Park, New Jersey, has recalled multiple lots of bisoprolol fumarate and hydrochlorothiazide tablets (brand name Ziac), because the tablets may have been cross contaminated with other products, according to a recall report published online by the Food and Drug Administration.

The global drug maker, which is headquartered in Mumbai, India, said testing of reserve samples showed presence of traces of ezetimibe, a cholesterol drug the company also produces, according to the recall, posted Dec. 1.

The recall involves an undeclared number of lots of tablets, from 2.5 mg to 6.25 mg dosages, in various sized bottles, manufactured in Madhya Pradesh, India for Glenmark Pharmaceuticals, Inc., USA.

These lots were recalled:

  • 30-tablet bottles, NDC-68462-878-30. Lot 17232401, exp. 11/2025.
  • 100-tablet bottles, NDC-68462-878-01. Lot 17232401, exp. 11/2025.
  • 500-tablet bottles, NDC-68462-878-05. Lots 17232401, exp. 11/2025 and 17240974, exp. 05/2026.

USA TODAY has reached out to Glenmark Pharmaceuticals. Neither Glenmark nor the FDA have issued guidance on what to do with the recalled tablets.

But according to GoodRx, anyone affected by a drug recall is advised to check their medication’s lot number, contact their pharmacist as well as their prescriber and throw away the recalled medication.

One Response

  1. I’m so glad you post these recalls on your forum. Some people would never know about them.

    For my high blood pressure (hypertension) and migraine headaches I take a beta-blocker called propranolol (generic for Inderal) and it works wonders for me.

Leave a Reply

Discover more from PHARMACIST STEVE

Subscribe now to keep reading and get access to the full archive.

Continue reading